Hiroshima Journal of Medical Sciences Volume 61 Issue 3
published_at 2012-09

Cytisin Amidophosphate : The New Cytoprotector

Zhumadilov Zhaxybay
Nurgozhin Talgat
Gulyaev Alexandr
Zhaugasheva Sabira
Gazaliyev Arystan
Ermekbayeva Bakytgul
Abuova Gulnara
Kenessary Almas
fulltext
219 KB
HiroshimaJMedSci_61_45.pdf
Abstract
This article describes the results of a clinical study of O, O dimethyl-N-cytinizylphosphate in healthy volunteers and 142 patients with the verified diagnosis of acute toxic hepatitis. The tolerability was good. The efficiency of the drug is considered to be very high, normalization of the state took less time in comparison with standard treatment; a significant improvement was achieved immediately after the first injection.
Keywords
Cytoprotector
Acute toxic hepatitis
Rights
(c) Hiroshima University Medical Press.